1) FDA Approves Lunsumio VELO™ for Subcutaneous Use in Follicular Lymphoma Date: 22 December 2025 What’s...
1) FDA Approves DAYBUE® STIX for Rett Syndrome (12 Dec 2025) What’s new: The U.S. FDA has given the green l...
Stay updated on pharma trends and marketplace opportunities.